CClinicalTrials.gg
Status unknownNCT05117801PETALEUpdated Nov 11, 2021

Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician

An interventional study of Petale in Petale, Hearing Disorders and Child Development, sponsored by Ramsay Générale de Santé. Status unknown at 1 site in France. Open to participants aged 9 Months to 3 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-11.

Sponsored by Ramsay Générale de Santé · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Nov 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jan 2021, registered Oct 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
9 Months to 3 Years
Sex
All
01

Study summary

The aim of this study is to confirm the value of this new version of Pétale® ((small equipment for testing the child's hearing) in the daily practice of general practitioners or pediatricians for the screening of hearing disorders in very young children.

Read the detailed description

The research procedure is auditory stimulation using Pétale® (small equipment for testing the child's hearing) based on the "orientation reflex" ("Ewing" test): the child is seated on the companion's knees between the two enclosures and the investigator observes whether or not he is attracted to a familiar calibrated noise coming from one side or the other.

02

Conditions studied

  • Petale
  • Hearing Disorders
  • Child Development

Browse trials for

03

In context

Hearing Disorders

61 studies on the registry are indexed under Hearing Disorders; 17 are open to participants now.

This study's planned enrollment of 300 is above the median of 31 across 41 interventional studies indexed under Hearing Disorders.

Browse Hearing Disorders studies →

Lead sponsor

Ramsay Générale de Santé is the lead sponsor of 42 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Months to 3 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Chil, girl or boy between 9 months and 3 years-old
  • Child seen in consultation by a general practitioner or a pediatrician whatever the reason for consultation
  • Child attached to a beneficiary of a social security scheme
  • Signature of informed consent by parents.

Exclusion criteria

Exclusion Criteria:

  • Age greater than 3 years and less than 9 months
  • Refusal of one or more parents during the consultation
  • State of the child which does not allow the screening test to be carried out
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    children at the general practitioner or pediatrician

    Children between 9 months and 3 years-old coming to their doctor for any consultation

    Device: Petale

Interventions

  • DevicePetale

    The child sits on the companion's lap between the two enclosures, and the investigator observes whether or not he is attracted to a familiar calibrated noise coming from one side or the other.

06

What researchers measure

Primary outcomes

  1. Sensitivity

    Proportion of children with a hearing impairment assessed by the investigator knowing that they were also assessed with a hearing impairment by ENT specialist.

    Time frame: 2 weeks

  2. Specificity

    Proportion of children without hearing impairment assessed by the investigator knowing that they were also assessed without hearing impairment by ENT.

    Time frame: 2 weeks

  3. Positive Predictive Value (PPV):

    Proportion of children with hearing impairment assessed by both investigator and ENT among children with hearing impairment assessed by ENT.

    Time frame: 2 weeks

  4. Negative Predictive Value (NPV)

    Proportion of children without hearing impairment assessed by both investigator and ENT among children without hearing impairment assessed by ENT.

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
  • Clinique Saint-Amé
    Lambres-lez-Douai, 59552, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05117801
Lead sponsor
Ramsay Générale de Santé
Collaborators
European Clinical Trial Experts Network
Responsible party
Sponsor
First posted
Nov 11, 2021
Start date
Jan 4, 2021
Primary completion
Oct 4, 2021
Completion
Jul 4, 2022 (estimated)
Last update
Nov 11, 2021

Study contacts

Jean-François Oudet
Contact
jf.oudet@ecten.eu
0683346567
Marie-Hélène Barba
Contact
mh.barba@ecten.eu

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion